Skip to main content

High risk HPV types in southern Iranian patients with cervical cancer

Pathology Oncology Research volume 9, pages 121–125 (2003)Cite this article

Abstract

This study was undertaken to assess the rate of HPV infection in cervical carcinoma among southern Iranian patients. 101 archival cervical carcinoma tissue samples of a 10 year period were studied for the presence of HPV DNA in southern Iran by a polymerase chain reaction method. In addition, the presence of high risk HPV-16 and HPV-18 genotypes was investigated. In total, 88 (87.1%) of the samples were HPV DNA positive, of which 83 were squamous cell carcinomas and 5 were adenocarcinomas. HPV-16 genotype was detected in 26.7% of HPV positive cervical carcinomas; however none of the samples were positive for the existence of HPV-18 genotype. Collectively, these results suggest that HPV-16 and HPV-18 are not the frequent high risk HPV types in our patients and circulating HPV types in southern Iranian population are different from many other populations.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2:533–543, 2001

    PubMed  Article  CAS  Google Scholar 

  2. Farahmandbeigi M, Kadivar MR: The incidence rate of registered cancer in Fars province. Disease Control Unit, Shiraz University Press, Iran, 2000

    Google Scholar 

  3. Bosch FX, Munoz N. The viral etiology of cervical cancer. Virus Res 89:183–190, 2002

    PubMed  Article  CAS  Google Scholar 

  4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19, 1999

    PubMed  Article  CAS  Google Scholar 

  5. Southern SA, Herrington CS. Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gynecol Cancer 10:263–274, 2000

    PubMed  Article  Google Scholar 

  6. Park TW, Fujiwara H, Wright TC. Molecular biology of cervical cancer and its precursors. Cancer 76:1902–1913, 1995

    PubMed  Article  CAS  Google Scholar 

  7. IARC working Group, Human papilloma viruses, IARC Monograph on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer, 65, 1995

    Google Scholar 

  8. Badaracco G, Venuti A, Sedati A, Marcante ML. HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 67:574–582, 2002

    PubMed  Article  CAS  Google Scholar 

  9. Munoz N, Franceschi S, Bosetti C, et al. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093–1101, 2002

    PubMed  Article  Google Scholar 

  10. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94:1406–1414, 2002

    PubMed  Google Scholar 

  11. Rong S, Chen W Wu L, et al. Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province Zhonghua Yu Fang Yi Xue Za Zhi 36:41–43, 2002

    Google Scholar 

  12. Mandelblatt JS, Lawrence WF, Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 287:2372–2381, 2002

    PubMed  Article  Google Scholar 

  13. Castellsague X, Menendez C, Loscertales MP, et al. Human papillomavirus genotypes in rural Mozambique. Lancet 358:1429–1430, 2001

    PubMed  Article  CAS  Google Scholar 

  14. Snijders PJ, van den Brule AJ, Schrijnemakers HF, et al. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71:173–181, 1990

    PubMed  Article  CAS  Google Scholar 

  15. Samoylova EV, Shaikhaiev GO, Petrov SV, et al. HPV infection in cervical cancer cases in Russia. Int J Cancer 61:337–341, 1995

    PubMed  Article  CAS  Google Scholar 

  16. Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000. Lancet Oncol 2:27–32, 2002

    Article  Google Scholar 

  17. Sebbelov AM, Davidson M, Kruger Kjaer S, et al. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect 2:121–126, 2000

    PubMed  Article  CAS  Google Scholar 

  18. Goncalves MA, Massad E, Burattini MN, Villa LL. Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, Sao Paulo, Brazil. Int J STD AIDS 10:803–807, 1999

    PubMed  Article  CAS  Google Scholar 

  19. Lo KW, Wong YF, Chan MK, et al. Prevalence of human papil-lomavirus in cervical cancer: a multicenter study in China. Int J Cancer 100:327–331, 2002

    PubMed  Article  CAS  Google Scholar 

  20. Baay MF, Tjalma WA, Weyler J, et al. Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer. Eur J Gynaecol Oncol 22:204–208, 2001

    PubMed  CAS  Google Scholar 

  21. Chen S, O’Sullivan H, Tabrizi SN, et al. Prevalence and genotyping of HPV in cervical cancer among Australian women. Int J Gynaecol Obstet 67:163–168, 1999

    PubMed  Article  CAS  Google Scholar 

  22. Chabaud M, Le Cann P, Mayelo V, et al. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol 49:259–263, 1996

    PubMed  Article  CAS  Google Scholar 

  23. Bestow AH, Gyllensten UB. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 101:526–531, 2002

    Article  CAS  Google Scholar 

  24. Zwaveling S, Ferreira Mota SC, Nouta J, et al. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J Immunol 169:350–358, 2002

    PubMed  CAS  Google Scholar 

  25. Dehaghani AS, Amirzargar A, Farjadian S, Ghaderi A. HLA-DQB1 alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients. Pathol Oncol Res 8:58–61, 2002

    PubMed  CAS  Article  Google Scholar 

  26. Amirzargar A, Mytilineos J, Farjadian Sh, et al. Human Leukocyte Antigen class II allele frequencies and haplotype association in Iranian population. Hum Immunol 62:1234–1238, 2001

    PubMed  Article  CAS  Google Scholar 

  27. Hording U, Teglbjaerg CS, Visfeldt J, Bock JE. Human papil-lomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Gynecol Oncol 46:313–316, 1992

    PubMed  Article  CAS  Google Scholar 

  28. Bjersing L, Rogo K, Evander M, et al. HPV 18 and cervical adenocarcinomas. Anticancer Res 11:123–127, 1991

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran

    S. Farjadian, M. Doroudchi & A. Ghaderi

  2. Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran

    E. Asadi, S. Z. Tabei & V. P. Kumar

  3. Shiraz Institute for Cancer Research (ICR), Shiraz University of Medical Sciences, P.O. Box:71345-3119, Shiraz, Iran

    M. Doroudchi & A. Ghaderi

  4. Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran

    A. Samsami Dehaghani

Authors
  1. S. Farjadian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Asadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Doroudchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Samsami Dehaghani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Z. Tabei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. P. Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Ghaderi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Ghaderi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Farjadian, S., Asadi, E., Doroudchi, M. et al. High risk HPV types in southern Iranian patients with cervical cancer. Pathol. Oncol. Res. 9, 121–125 (2003). https://doi.org/10.1007/BF03033756

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033756

Keywords

  • cervical cancer
  • HPV